Should the pharmaceutical manufacturer has several suppliers, then these suppliers should also be assessed by classifying them into diverse concentrations dependent on their own influence on the medicinal item.“It makes it tough to propose that bringing every one of the API manufacturing back towards the US and Europe solves the issue. It doesn�